Skip Navigation

Cardiovascular Research 1997 33(1):88-97; doi:10.1016/S0008-6363(96)00187-3
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Davia, K
Right arrow Articles by Harding, S.E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davia, K
Right arrow Articles by Harding, S.E
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Effects of inhibition of sarcoplasmic reticulum calcium uptake on contraction in myocytes isolated from failing human ventricle

K Davia, C.H Daviesa and S.E Harding*

Cardiac Medidine, National Heart and Lung Institute, Imperial College, London SW3 6LY, UK

Objectives: There has been debate regarding the level of sarcoplasmic reticulum (SR) Ca2+ ATPase protein in heart failure. We have used the SR Ca2+ ATPase inhibitor thapsigargin to investigate the functional contribution of this uptake system to contraction and relaxation in myocytes from failing and non-failing human ventricle. Methods: Myocytes were isolated from 28 failing and 18 non-failing ventricles and stimulated at 0.2 Hz, 32°C in Krebs-Henseleit solution. Contraction amplitude and speed were compared before and after treatment with 1 µmol/l thapsigargin for 20 min to deplete SR Ca2+ stores. Results: Initial beat duration was longer in myocytes from failing hearts. Addition of thapsigargin significantly prolonged the beat in myocytes from both groups, but the increase was greater in non-failing hearts (beat duration increased by 0.79 ± 0.12 s in myocytes from non-failing hearts compared with 0.37 ± 0.12 s in those from failing, P < 0.02). The contraction amplitude increased at high stimulation frequencies in myocytes from non-failing hearts (from 2.6% shortening at 0.1 Hz to 4.6% at 1 Hz, P < 0.001, n = 9), but not in those from failing hearts (1.8% at 0.1 Hz compared with 1.7% at 1 Hz, n = 5). Thapsigargin abolished the positive staircase in the non-failing, but had no effect in the failing group. Contraction amplitude following a rest interval was significantly depressed relative to steady-state levels in myocytes from the non-failing hearts (44.8 ± 10.3% at 3 min), but not in failing (102 ± 18%, P < 0.01 compared to non-failing at 3 min). Following thapsigargin treatment, there were no longer significant differences between failing and non-failing myocytes in the time course of the beat, frequency response or post-rest behaviour. Conclusion: The differences between myocytes from failing and non-failing hearts were reduced by inhibition of SR function. These results are consistent with the hypothesis that the initial differences had been due to decreased SR Ca2+ uptake.

KEYWORDS Human, ventricular myocytes; Relaxation; Sarcoplasmic reticulum; Heart failure; SR Ca-ATPase; Thapsigargin


a Current address: Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, UK.

* Corresponding author. Tel. +44 171 352-8121, ext. 3311; Fax +44 171 823-3392; E-mail sian.harding @ic.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HeartHome page
B M Mayosi, A Kardos, C H Davies, F Gumedze, A Hovnanian, S Burge, and H Watkins
Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure
Heart, January 1, 2006; 92(1): 105 - 109.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Zorn-Pauly, P. Schaffer, B. Pelzmann, E. Bernhart, G. Wei, P. Lang, G. Ledinski, J. Greilberger, B. Koidl, and G. Jurgens
Oxidized LDL induces ventricular myocyte damage and abnormal electrical activity-role of lipid hydroperoxides
Cardiovasc Res, April 1, 2005; 66(1): 74 - 83.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. S Maier, C. Schwan, W. Schillinger, K. Minami, U. Schutt, and B. Pieske
Gingerol, isoproterenol and ouabain normalize impaired post-rest behavior but not force-frequency relation in failing human myocardium
Cardiovasc Res, March 1, 2000; 45(4): 913 - 924.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Chandrashekhar, A. J. Prahash, S. Sen, S. Gupta, and I. S. Anand
Cardiomyocytes from hearts with left ventricular dysfunction after ischemia-reperfusion do not manifest contractile abnormalities
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 594 - 602.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Gaughan, S. Furukawa, V. Jeevanandam, C. A. Hefner, H. Kubo, K. B. Margulies, B. S. McGowan, J. A. Mattiello, K. Dipla, V. Piacentino III, et al.
Sodium/calcium exchange contributes to contraction and relaxation in failed human ventricular myocytes
Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H714 - H724.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Dipla, J. A. Mattiello, K. B. Margulies, V. Jeevanandam, and S. R. Houser
The Sarcoplasmic Reticulum and the Na+/Ca2+ Exchanger Both Contribute to the Ca2+ Transient of Failing Human Ventricular Myocytes
Circ. Res., March 5, 1999; 84(4): 435 - 444.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. E. Harding, C. H. Davies, A. M. Money-Kyrle, and P. A. Poole-Wilson
An inhibitor of nitric oxide synthase does not increase contraction or {beta}-adrenoceptor sensitivity of ventricular myocytes from failing human heart
Cardiovasc Res, December 1, 1998; 40(3): 523 - 529.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Meyer and W. H Dillmann
Sarcoplasmic reticulum Ca2+-ATPase overexpression by adenovirus mediated gene transfer and in transgenic mice
Cardiovasc Res, February 1, 1998; 37(2): 360 - 366.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. R Sipido, T. Stankovicova, W. Flameng, J. Vanhaecke, and F. Verdonck
Frequency dependence of Ca2+ release from the sarcoplasmic reticulum in human ventricular myocytes from end-stage heart failure
Cardiovasc Res, February 1, 1998; 37(2): 478 - 488.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. R.W. Money-Kyrle, C. H. Davies, H. K. Ranu, P. O'Gara, N. Singh Kent, P. A. Poole-Wilson, and S. E. Harding
The role of cAMP in the frequency-dependent changes in contraction of guinea-pig cardiomyocytes
Cardiovasc Res, February 1, 1998; 37(2): 532 - 540.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
K. DAVIA, R. J. HAJJAR, C. M. N. TERRACCIANO, N. S. KENT, H. K. RANU, P. O'GARA, A. ROSENZWEIG, and S. E. HARDING
Functional alterations in adult rat myocytes after overexpression of phospholamban with use of adenovirus
Physiol Genomics, August 31, 1999; 1(2): 41 - 50.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.